ADCT vs UTHR · rev $40.1M vs P/E 20, rev $1.56B
ADC Therapeutics SA (ADCT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ADCT currently screens at market cap $141.2M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ADCT and UTHR stock pages for the full models.
Not investment advice.